A Conversation with Cushman & Wakefield
The editorial team at LevinPro HC attended BOMA International’s Medical Real Estate Conference last week and sat down with Lorie Damon, who leads the healthcare advisory practice at Cushman & Wakefield. Below is the Q&A of the conversation covering the medical...
Fragmented ASC Market Poised for M&A Growth
As the healthcare market moves toward a value-based care model, outpatient settings and services will only rise in demand from investors and patients alike. Ambulatory surgery centers, or ASCs, will be one of the most valuable assets in this shift in the healthcare...Why Invest in the Health Clinic Market
We sat down and spoke with industry expert Andre Ulloa, Partner and Executive Advisor of M&A Healthcare Advisors, to discuss the key considerations investors should know before investing in the health clinic market. Ulloa sheds light on the factors driving...Why Invest in the ENT Market
The ear, nose and throat (ENT) market, also known as otolaryngology, encompasses a wide range of services. For our purposes, we categorize all ENT and allergy-related services under the ENT subsector. This classification is based on the comprehensive expertise of...Why Invest In The Nephrology Market
Historically, nephrology has not seen a large amount of investment activity. In the past few years, there have only been a handful of transactions. According to data captured in the LevinPro HC database, in 2021 there were only five transactions. In 2022, there...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
